Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01666418
Recruitment Status : Unknown
Verified December 2014 by University of Zurich.
Recruitment status was:  Active, not recruiting
First Posted : August 16, 2012
Last Update Posted : December 3, 2014
Information provided by (Responsible Party):
University of Zurich

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : October 2014
  Estimated Study Completion Date : May 2015